SCHEMBL29839755

SCHEMBL29839755

COc1cc(-c2c(-n3cc(C(F)(F)F)nn3)ccc(Cl)c2F)c(OC)cn1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 14/20 0.40
▸ KLK1 P06870 1/20 0.38
▸ KLKB1 P03952 10/20 0.38
▸ CYP3A4 P08684 4/20 0.37
▸ NOTUM Q6P988 4/20 0.36
▸ F2 P00734 1/20 0.35
▸ F10 P00742 1/20 0.35
▸ CYP1A1 P04798 1/20 0.35
▸ PRSS1 P07477 1/20 0.35
▸ PRSS2 P07478 1/20 0.35
▸ CYP2C8 P10632 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ PRSS3 P35030 1/20 0.35
▸ AR P10275 1/20 0.35
▸ RXRA P19793 1/20 0.34
▸ GRIN1 Q05586 1/20 0.34
▸ GRIN2B Q13224 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27003504 1.00 F11 (0.40) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL31174071 0.91 F11 (0.40) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL30590414 0.84 F11 (0.39) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL21357595 0.83 F11 (0.49) F11KLKB1CYP3A4F2F10
SCHEMBL29697761 0.83 F11 (0.49) F11KLKB1CYP3A4F2F10
SCHEMBL30995051 0.82 F11 (0.41) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL16971771 0.82 F11 (0.38) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL29227936 0.82 F11 (0.41) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL29839754 0.81 F11 (0.40) F11KLK1KLKB1CYP3A4NOTUM
SCHEMBL29839752 0.81 F11 (0.40) F11KLK1KLKB1CYP3A4NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4304714-A1 CRYSTALLINE FORMS OF (4S)-2 4-CHLORO-4-ETHYL-7 3-FLUORO-3 5-METHOXY-3 2,5-DIOXO-1 4-(TRIFLUOROMETHYL)-3 2H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-5 DIBENZENAHEPTAPHANE-7 4-CARBOXAMIDE Bayer Aktiengesellschaft (DE) 2024-01-17 — — EP disclosed
EP-4304561-A1 PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5- DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)- DIBENZENAHEPTAPHANE-74-CARBOXAMIDE Bayer Aktiengesellschaft (DE) 2024-01-17 — — EP disclosed
CN-117337170-A Comprises (4S) -2 4 -chloro-4-ethyl-7 3 -fluoro-3 5 -methoxy-3 2 5-dioxo-1 4 - (trifluoromethyl) -3 2 H-6-aza-3 (4, 1) -pyridine-1 (1) - [1,2,3]Triazole-2 (1, 2), 7 (1) -diphenyl heptatomato-7 4 Pharmaceutical dosage form of formamide 拜耳公司 2024-01-02 — — CN disclosed
CN-117015535-A (4S)-2 4 -chloro-4-ethyl-7 3 -fluoro-3 5 -methoxy-3 2 5-dioxo-1 4 - (trifluoromethyl) -3 2 H-6-aza-3 (4, 1) -pyridine-1 (1) - [1,2,3]Triazole-2 (1, 2), 7 (1) -5-diphenylheptane-7 4 Crystalline forms of formamide 拜耳公司 2023-11-07 — — CN disclosed
WO-2022189278-A1 PHARMACEUTICAL DOSAGE FORMS COMPRISING (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5- DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)- DIBENZENAHEPTAPHANE-74-CARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2022-09-15 — — WO disclosed
WO-2022189279-A1 CRYSTALLINE FORMS OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUOROMETHYL)-32H-6-AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-5 DIBENZENAHEPTAPHANE-74-CARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2022-09-15 — — WO disclosed
WO-2022189280-A1 SOLVATES OF (4S)-24-CHLORO-4-ETHYL-73-FLUORO-35-METHOXY-32,5-DIOXO-14-(TRIFLUORO-METHYL)-32 H-6- AZA-3(4,1)-PYRIDINA-1(1)-[1,2,3]TRIAZOLA-2(1,2),7(1)-DIBENZENAHEPTAPHANE-74-CARBOXAMIDE BAYER AKTIENGESELLSCHAFT (DE) 2022-09-15 — — WO disclosed
Send feedback